Mode
Text Size
Log in / Sign up

Machine learning and deep learning applications in inguinal hernia care show promise for risk prediction and training.

Machine learning and deep learning applications in inguinal hernia care show promise for risk predic…
Photo by Europeana / Unsplash
Key Takeaway
Note that ML and DL predict hernia risks effectively, but generative AI accuracy requires further validation.

This narrative review examines the current landscape of machine learning (ML) and deep learning (DL) applications within inguinal hernia care. The analysis focuses on diagnostic accuracy, surgical protocols, and patient outcomes, specifically highlighting the potential for prediction of postoperative surgical site infection, surgical site occurrence, intestinal resection in incarcerated inguinal hernia, and postoperative lower extremity venous thromboembolism. Additionally, the review addresses the utility of these technologies in identifying anatomical landmarks, providing real-time feedback, and enhancing surgical training.

Main results indicate that models developed using ML can effectively predict the risks associated with postoperative surgical site infection, surgical site occurrence, intestinal resection in incarcerated inguinal hernia, and postoperative lower extremity venous thromboembolism. Deep learning is described as highly effective for the identification of anatomical landmarks. However, the accuracy and reliability of generative AI were noted to require further validation.

No specific safety data, adverse events, or discontinuations were reported in this narrative review. The primary limitation identified is that the accuracy and reliability of generative AI require further validation. As a narrative review, the study does not provide randomized controlled trial data or specific statistical measures such as absolute numbers or p-values to quantify these findings.

The practice relevance of this evidence lies in offering references for clinical practice and technological innovation. Clinicians should interpret these findings as exploratory. While ML and DL show promise for risk prediction and training, the current evidence is insufficient to mandate their use. Further high-quality studies are needed to confirm efficacy and safety before widespread implementation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
With the rapid development of artificial intelligence (AI) technology, its application in the diagnosis and treatment of inguinal hernia (IH) has gradually become a research hotspot. As core components of AI, machine learning (ML) and deep learning (DL) demonstrate tremendous potential in medical imaging, disease prediction, and personalized treatment planning. Currently, models developed using ML can effectively predict the risks of postoperative surgical site infection, surgical site occurrence, intestinal resection in incarcerated IH, and postoperative lower extremity venous thromboembolism. DL, as a subset of ML, excels in processing unstructured data such as images and videos. It utilizes deep neural networks to automatically extract data features, thereby enhancing medical image diagnosis and intraoperative navigation capabilities. Studies have shown that DL is highly effective in identifying anatomical landmarks during surgery, which facilitates real-time feedback and surgical training. Generative AI, built on ML theories, shows promise in medical consultations, but its accuracy and reliability require further validation. Overall, ML and DL are revolutionizing the management of IH by improving diagnostic accuracy, optimizing surgical protocols, and enhancing patient outcomes. Future prospects include data integration, real-time feedback, and interdisciplinary collaboration. This article provides a review of the applications of ML and DL in the diagnosis and treatment of IH, offering references for clinical practice and technological innovation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.